Visomitin (SKQ1) | 98.17%(HPLC) | In Stock | Others
Matching Dry Eye Treatments to Patient Type - Modern Optometry
Cells | Free Full-Text | Corneal Edema in Inducible Slc4a11 Knockout Is Initiated by Mitochondrial Superoxide Induced Src Kinase Activation
Buy VISOMITIN® (SKQ1, Skulachev Ions) for eye health, 5ml
Pharmaceutics | Free Full-Text | A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives
Evaluating the Stability of a Cationic Plastoquinone Derivative (PDTP) in Visomitin Eye Drops | SpringerLink
Buy VISOMITIN® (SKQ1, Skulachev Ions) for eye health, 5ml
Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review - ScienceDirect
Current trends in pharmaceutical treatment of dry eye disease: A review - ScienceDirect
Buy VISOMITIN ® (SkQ1 / Skulachev Ions) - CosmicNootropic
The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface | Ophthalmology and Therapy
Frontiers | Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics?
VISOMITIN® Eye Drops with Skulachev ion
Delving into the Dry-Eye Pipeline
VISOMITIN eye drops by Mitotech S.A. (Luxembourg) SKQ-1 Skulachev Russ
Frontiers | PM10 and Pseudomonas aeruginosa: effects on corneal epithelium
Novel Dry Eye Disease Therapeutics and the Tools Used to Assess Them
Dry Eye: What's in the Pipeline?
Cells | Free Full-Text | Corneal Edema in Inducible Slc4a11 Knockout Is Initiated by Mitochondrial Superoxide Induced Src Kinase Activation
New for 2020 and beyond: Dry eye disease agents in pipeline
Cells | Free Full-Text | Corneal Edema in Inducible Slc4a11 Knockout Is Initiated by Mitochondrial Superoxide Induced Src Kinase Activation
